Download - WHOCC

QD06C
ANTIBIOTICS AND CHEMOTERAPEUTICS, COMBINATIONS
QD07
CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
As a general rule, all topical corticosteroid preparations should be classified in this
group. There are, however, a few exceptions: for most antifungal products with
corticosteroids, the primary indication is mycosis and not inflammation, and these
preparations should be classified in QD01A - Antifungals for topical use.
Corticosteroids, antiseptics and salicylic acid in combination are classified in
QD07X - Corticosteroids, other combinations.
See also:
QA01AC - Corticosteroids for local oral treatment
QS - Sensory organs
QD07A
CORTICOSTEROIDS, PLAIN
The group is subdivided according to the clinical potency of the steroids as such.
Additional agents meant to enhance the penetration and increase the potency of the
preparation do not influence the classification, nor does the strength of the
preparations or the vehicle. Combined preparations are classified in
QD07B - Corticosteroids, combination with antiseptics, QD07C - Corticosteroids,
combinations with antibiotics and QD07X - Corticosteroids, other combinations.
QD07AA Corticosteroids, weak (group I)
QD07AB
QD07AC
QD07AD
Corticosteroids, moderately potent (group II)
Corticosteroids, potent (group III)
Corticosteroids, very potent (group IV)
QD07B
CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS
Combined corticosteroid/antiseptic preparations for dermatological use are
classified in this group. The group is subdivided according to clinical potency, see
QD07A. Exceptions, see the comment on QD07. In each 5th level group various
antiseptics may occur.
QD07BA
QD07BB
QD07BC
QD07BD
Corticosteroids, weak, combinations with antiseptics
Corticosteroids, moderately potent, combinations with antiseptics
Corticosteroids, potent, combinations with antiseptics
Corticosteroids, very potent, combinations with antiseptics
66